160 related articles for article (PubMed ID: 10348753)
1. OXA-17, a further extended-spectrum variant of OXA-10 beta-lactamase, isolated from Pseudomonas aeruginosa.
Danel F; Hall LM; Duke B; Gur D; Livermore DM
Antimicrob Agents Chemother; 1999 Jun; 43(6):1362-6. PubMed ID: 10348753
[TBL] [Abstract][Full Text] [Related]
2. OXA-16, a further extended-spectrum variant of OXA-10 beta-lactamase, from two Pseudomonas aeruginosa isolates.
Danel F; Hall LM; Gur D; Livermore DM
Antimicrob Agents Chemother; 1998 Dec; 42(12):3117-22. PubMed ID: 9835501
[TBL] [Abstract][Full Text] [Related]
3. OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strain.
Danel F; Hall LM; Gur D; Livermore DM
Antimicrob Agents Chemother; 1997 Apr; 41(4):785-90. PubMed ID: 9087490
[TBL] [Abstract][Full Text] [Related]
4. OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa.
Hall LM; Livermore DM; Gur D; Akova M; Akalin HE
Antimicrob Agents Chemother; 1993 Aug; 37(8):1637-44. PubMed ID: 8215276
[TBL] [Abstract][Full Text] [Related]
5. Novel OXA-10-derived extended-spectrum beta-lactamases selected in vivo or in vitro.
Mugnier P; Casin I; Bouthors AT; Collatz E
Antimicrob Agents Chemother; 1998 Dec; 42(12):3113-6. PubMed ID: 9835500
[TBL] [Abstract][Full Text] [Related]
6. OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa.
Philippon LN; Naas T; Bouthors AT; Barakett V; Nordmann P
Antimicrob Agents Chemother; 1997 Oct; 41(10):2188-95. PubMed ID: 9333046
[TBL] [Abstract][Full Text] [Related]
7. OXA-28, an extended-spectrum variant of OXA-10 beta-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene.
Poirel L; Girlich D; Naas T; Nordmann P
Antimicrob Agents Chemother; 2001 Feb; 45(2):447-53. PubMed ID: 11158739
[TBL] [Abstract][Full Text] [Related]
8. Laboratory mutants of OXA-10 beta-lactamase giving ceftazidime resistance in Pseudomonas aeruginosa.
Danel F; Hall LM; Livermore DM
J Antimicrob Chemother; 1999 Mar; 43(3):339-44. PubMed ID: 10223588
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
Aktaş Z; Kayacan C; Oncul O
Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
[TBL] [Abstract][Full Text] [Related]
10. OXA-35 is an OXA-10-related beta-lactamase from Pseudomonas aeruginosa.
Aubert D; Poirel L; Ali AB; Goldstein FW; Nordmann P
J Antimicrob Chemother; 2001 Nov; 48(5):717-21. PubMed ID: 11679562
[TBL] [Abstract][Full Text] [Related]
11. Ceftazidime-hydrolysing β-lactamase OXA-145 with impaired hydrolysis of penicillins in Pseudomonas aeruginosa.
Hocquet D; Colomb M; Dehecq B; Belmonte O; Courvalin P; Plésiat P; Meziane-Cherif D
J Antimicrob Chemother; 2011 Aug; 66(8):1745-50. PubMed ID: 21665906
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of a new β-lactamase OXA-205 from Pseudomonas aeruginosa.
Krasauskas R; Labeikytė D; Markuckas A; Povilonis J; Armalytė J; Plančiūnienė R; Kavaliauskas P; Sužiedėlienė E
Ann Clin Microbiol Antimicrob; 2015 Nov; 14():52. PubMed ID: 26611758
[TBL] [Abstract][Full Text] [Related]
13. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
Er H; Altındiş M; Aşık G; Demir C
Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816
[TBL] [Abstract][Full Text] [Related]
14. OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa.
Danel F; Hall LM; Gur D; Livermore DM
Antimicrob Agents Chemother; 1995 Aug; 39(8):1881-4. PubMed ID: 7486940
[TBL] [Abstract][Full Text] [Related]
15. Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal.
Féria C; Ferreira E; Correia JD; Gonçalves J; Caniça M
J Antimicrob Chemother; 2002 Jan; 49(1):77-85. PubMed ID: 11751770
[TBL] [Abstract][Full Text] [Related]
16. Transferable production of PER-1 beta-lactamase in Pseudomonas aeruginosa.
Danel F; Hall LM; Gur D; Akalin HE; Livermore DM
J Antimicrob Chemother; 1995 Feb; 35(2):281-94. PubMed ID: 7759392
[TBL] [Abstract][Full Text] [Related]
17. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
[TBL] [Abstract][Full Text] [Related]
18. CTX-M-15 and OXA-10 beta lactamases in multi drug resistant Pseudomonas aeruginosa: First report from Pakistan.
Ullah W; Qasim M; Rahman H; Khan S; Rehman ZU; Ali N; Muhammad N
Microb Pathog; 2017 Apr; 105():240-244. PubMed ID: 28258003
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters.
Mushtaq S; Warner M; Livermore DM
J Antimicrob Chemother; 2010 Nov; 65(11):2376-81. PubMed ID: 20801783
[TBL] [Abstract][Full Text] [Related]
20. Outbreak of PER-1 and diversity of β-lactamases among ceftazidime-resistant Pseudomonas aeruginosa clinical isolates.
Qing Y; Cao KY; Fang ZL; Huang YM; Zhang XF; Tian GB; Huang X
J Med Microbiol; 2014 Mar; 63(Pt 3):386-392. PubMed ID: 24398232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
